← Leaderboards
Ervin Steve Woodle
University Of Pennsylvania
$1,131,466
Attributed
$3,394,398
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $701.2K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,394,398 · 1
By mechanism
R01$3,394,398 · 1
Top collaborators
- David M Allman5 shared
- David A Hildeman5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ali Naji$46,943,355
- David M Allman$20,049,239
- Surafel Mulugeta$3,909,502
- Mark L Kahn$46,704,160
- Pamela Jeannette Sung$1,023,084
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteDrug UsageAffectAntibodiesAlloantigenAntigensApoptosisApoptoticAreaAutoimmunityAutomobile DrivingAntibody Titer MeasurementBim Bcl-2-Binding ProteinBiochemicalBone MarrowBortezomibCell DeathCell PhysiologyCell SurvivalCellular BiologyCessation Of LifeChronicDrug ResistanceEndoplasmic Reticulum Stress
Grant awards (5)
Proteasome targeting for alloreactive plasma cells$656,105
R01 · FY2024 · AI
Proteasome targeting for alloreactive plasma cells$656,561
R01 · FY2023 · AI
Proteasome targeting for alloreactive plasma cells$688,803
R01 · FY2022 · AI
Proteasome targeting for alloreactive plasma cells$691,721
R01 · FY2021 · AI
Proteasome targeting for alloreactive plasma cells$701,208
R01 · FY2020 · AI